Memorial Sloan Kettering Cancer Center
Clinical trials sponsored by Memorial Sloan Kettering Cancer Center, explained in plain language.
-
Triple-Drug attack shows promise for Tough-to-Treat melanoma
Disease control Recruiting nowThis study tests whether a combination of three drugs (fianlimab, cemiplimab, and ipilimumab) is safe and effective for people with advanced melanoma that no longer responds to standard immunotherapy. About 88 adults with locally advanced or metastatic melanoma will participate. …
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
Can acupuncture ease cancer Survivors' joint pain? new study aims to find out
Symptom relief Recruiting nowThis study looks at whether acupuncture is a practical option for cancer survivors who have ongoing joint pain. Researchers want to see if it's possible to run a larger study on this topic. The study will include 60 English- or Spanish-speaking adults from diverse backgrounds who…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Apr 26, 2026 20:03 UTC